Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $117.50 million. The enterprise value is $98.34 million.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 17.18 million shares outstanding. The number of shares has increased by 112.96% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +112.96% |
| Shares Change (QoQ) | +51.00% |
| Owned by Insiders (%) | 29.16% |
| Owned by Institutions (%) | 22.66% |
| Float | 7.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.16 |
| Forward PS | 4.25 |
| PB Ratio | 7.32 |
| P/TBV Ratio | 7.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.10 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -20.88% |
| Return on Invested Capital (ROIC) | -40.88% |
| Return on Capital Employed (ROCE) | -59.93% |
| Weighted Average Cost of Capital (WACC) | 16.09% |
| Revenue Per Employee | $488,961 |
| Profits Per Employee | -$234,553 |
| Employee Count | 76 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 6.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.00% in the last 52 weeks. The beta is 1.49, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +14.00% |
| 50-Day Moving Average | 6.35 |
| 200-Day Moving Average | 5.93 |
| Relative Strength Index (RSI) | 63.17 |
| Average Volume (20 Days) | 43,765 |
Short Selling Information
The latest short interest is 379,278, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 379,278 |
| Short Previous Month | 412,480 |
| Short % of Shares Out | 2.21% |
| Short % of Float | 4.80% |
| Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, VRCA had revenue of $37.16 million and -$17.83 million in losses. Loss per share was -$1.31.
| Revenue | 37.16M |
| Gross Profit | 22.84M |
| Operating Income | -13.52M |
| Pretax Income | -17.83M |
| Net Income | -17.83M |
| EBITDA | -13.06M |
| EBIT | -13.52M |
| Loss Per Share | -$1.31 |
Full Income StatementBalance Sheet
The company has $20.60 million in cash and $1.44 million in debt, giving a net cash position of $19.16 million or $1.12 per share.
| Cash & Cash Equivalents | 20.60M |
| Total Debt | 1.44M |
| Net Cash | 19.16M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 16.06M |
| Book Value Per Share | 0.93 |
| Working Capital | 17.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.11M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 466,000 |
| Net Borrowing | -44.26M |
| Free Cash Flow | -14.11M |
| FCF Per Share | -$0.82 |
Full Cash Flow StatementMargins
Gross margin is 61.45%, with operating and profit margins of -36.39% and -47.97%.
| Gross Margin | 61.45% |
| Operating Margin | -36.39% |
| Pretax Margin | -47.97% |
| Profit Margin | -47.97% |
| EBITDA Margin | -35.14% |
| EBIT Margin | -36.39% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -112.96% |
| Shareholder Yield | -112.96% |
| Earnings Yield | -15.17% |
| FCF Yield | -12.01% |
Analyst Forecast
The average price target for VRCA is $15.54, which is 127.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.54 |
| Price Target Difference | 127.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 24.18% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -9.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.87 |
| Piotroski F-Score | 4 |